A Phase 1, Open-Label, Dose Escalation, Safety, and Tolerability Study of INCB054828 in Subjects with Advanced Malignancies

Sponsor
Incyte

Protocol Number
Incyte INCB 54828-101

To Learn More Call
201-510-0910